Last updated: 24 July 2019 at 7:21pm EST

Beatrice J Cazala Net Worth




The estimated Net Worth of Beatrice J Cazala is at least 13.7 百万$ dollars as of 31 May 2013. Beatrice Cazala owns over 91,282 units of Bristol-Myers Squibb Co stock worth over 8,424,243$ and over the last 16 years Beatrice sold BMY stock worth over 5,324,254$.

Beatrice Cazala BMY stock SEC Form 4 insiders trading

Beatrice has made over 22 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently Beatrice sold 91,282 units of BMY stock worth 4,290,254$ on 31 May 2013.

The largest trade Beatrice's ever made was exercising 179,678 units of Bristol-Myers Squibb Co stock on 7 March 2013 worth over 2,474,166$. On average, Beatrice trades about 32,240 units every 67 days since 2009. As of 31 May 2013 Beatrice still owns at least 173,374 units of Bristol-Myers Squibb Co stock.

You can see the complete history of Beatrice Cazala stock trades at the bottom of the page.



What's Beatrice Cazala's mailing address?

Beatrice's mailing address filed with the SEC is ROUTE 206 & PROVINCE LINE ROAD, , PRINCETON, NJ, 08543.

Insiders trading at Bristol-Myers Squibb Co

Over the last 16 years, insiders at Bristol-Myers Squibb Co have traded over 318,151,721$ worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth 6,601,565$ . The most active insiders traders include Lamberto AndreottiJames M CorneliusGiovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of 1,682,720$. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth 51,554$.



What does Bristol-Myers Squibb Co do?

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.



Complete history of Beatrice Cazala stock trades at Bristol-Myers Squibb Co

インサイダー
取引
取引
合計金額
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
販売 4,290,254$
31 May 2013
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
販売 1,034,000$
30 May 2013
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 2,782,247$
23 May 2013
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 2,474,166$
7 Mar 2013
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 135,747$
6 Mar 2013
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 3,927,516$
10 Aug 2012
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 1,862,531$
6 Mar 2012
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 527,952$
1 Mar 2012
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 70,832$
12 Mar 2011
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 201,449$
6 Mar 2011
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 172,373$
2 Mar 2011
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 861,151$
1 Mar 2011
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 82,550$
1 Jul 2010
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 59,269$
5 Apr 2010
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 69,411$
12 Mar 2010
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 192,659$
6 Mar 2010
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 411,489$
2 Mar 2010
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 63,710$
1 Mar 2010
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 67,993$
1 Jul 2009
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 44,656$
5 Apr 2009
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 55,711$
12 Mar 2009
Beatrice J Cazala
SVP Comm Ops、Pres GC Euro EM
オプション行使 73,895$
6 Mar 2009


Bristol-Myers Squibb Co executives and stock owners

Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: